Crossmark

Stereotactic ablative radiotherapy and systemic treatments for extracerebral oligometastases, oligorecurrence, oligopersistence and oligoprogression from lung cancer

Crossref DOI link: https://doi.org/10.1186/s12885-019-6449-8

Published Online: 2019-12-19

Published Print: 2019-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Kissel, Manon https://orcid.org/0000-0001-8255-4565
Martel-Lafay, Isabelle

Lequesne, Justine

Faivre, Jean-Christophe

Le Péchoux, Cécile

Stefan, Dinu

Barraux, Victor

Loiseau, Cédric

Grellard, Jean-Michel

Danhier, Serge

Lerouge, Delphine

Chouaid, Christos

Gervais, Radj

Thariat, Juliette
License Information

Text and Data Mining valid from 2019-12-01

Version of Record valid from 2019-12-19
More Information

Article History

Received: 27 May 2019

Accepted: 11 December 2019

First Online: 19 December 2019

Ethics approval and consent to participate

: yesThis retrospective study was institutional review-board, INDS (Institut National des Données de Santé), CEREES (Comité d’Expert pour les Recherches, les Etudes et les Evaluations dans le domaine de la Santé) and CNIL (Commission Nationale de l’Informatique et des Libertés) -approved.

: not applicable.

: The authors declare that they have no competing interests.

Document is current

Any future updates will be listed below